Ruxu You
Biographic Data
| ID | 10000035 |
|---|---|
| NAME | Ruxu You |
| GIVEN NAMES | Ruxu |
| FAMILY NAME | You |
| SIGNATURE | YOU R |
| AFFILIATIONS | Union Hospital |
| ORCID | 0000-0003-3057-4462 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 4 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Cost-effectiveness analysis of Chinese patent medicines for the treatment of postmenopausal osteoporosis in China
Introduction: Evidence indicates that Chinese patent medicines can significantly increase bone mass in patients with osteoporosis and alleviate symptoms associated with low bone density. Although the therapeutic effects of these two drugs have been compared both directly and indirectly, no economic-related studies currently exist. Therefore, this study aims to assess the cost-effectiveness of Xianling Gubao Capsules compared to Jintiange Capsules…
Factors affecting the medication literacy of older adults and targeted initiatives for improvement
Introduction This study explored the state of rational drug use among older adults in central China, aiming to unveil factors influencing their medication literacy and proposing targeted improvement measures. Methods A cross-sectional study involving 454 participants aged 60 and above was conducted in Hubei province between February 1 and May 30, 2023, with data collected through face-to-face interviews by pharmacists. Multiple logistic regressio…
Cost-Effectiveness of Sequential Teriparatide/Zoledronic Acid Compared With Zoledronic Acid Monotherapy for Postmenopausal Osteoporotic Women in China
Objective: We aimed to assess the cost-effectiveness of sequential teriparatide/zoledronic acid relative to zoledronic acid monotherapy for postmenopausal osteoporotic women in China. Methods: A previously validated Markov microsimulation model was updated to examine the cost-effectiveness of daily subcutaneous teriparatide for 2 years followed by annual intravenous zoledronic acid for 3 years (sequential teriparatide/zoledronic acid), compared w…
Cost-Effectiveness of Elbasvir/Grazoprevir for the Treatment of Chronic Hepatitis C
No prominent works on this page.
Cost-Effectiveness of Sequential Teriparatide/Zoledronic Acid Compared With Zoledronic Acid Monotherapy for Postmenopausal Osteoporotic Women in China
Objective: We aimed to assess the cost-effectiveness of sequential teriparatide/zoledronic acid relative to zoledronic acid monotherapy for postmenopausal osteoporotic women in China. Methods: A previously validated Markov microsimulation model was updated to examine the cost-effectiveness of daily subcutaneous teriparatide for 2 years followed by annual intravenous zoledronic acid for 3 years (sequential teriparatide/zoledronic acid), compared w…
Cost-Effectiveness of Elbasvir/Grazoprevir for the Treatment of Chronic Hepatitis C
Factors affecting the medication literacy of older adults and targeted initiatives for improvement
Introduction This study explored the state of rational drug use among older adults in central China, aiming to unveil factors influencing their medication literacy and proposing targeted improvement measures. Methods A cross-sectional study involving 454 participants aged 60 and above was conducted in Hubei province between February 1 and May 30, 2023, with data collected through face-to-face interviews by pharmacists. Multiple logistic regressio…
Cost-effectiveness analysis of Chinese patent medicines for the treatment of postmenopausal osteoporosis in China
Introduction: Evidence indicates that Chinese patent medicines can significantly increase bone mass in patients with osteoporosis and alleviate symptoms associated with low bone density. Although the therapeutic effects of these two drugs have been compared both directly and indirectly, no economic-related studies currently exist. Therefore, this study aims to assess the cost-effectiveness of Xianling Gubao Capsules compared to Jintiange Capsules…
Internal Medicine (3 works) · Medicine (3 works) · Bone health and osteoporosis research (2 works) · Bone Metabolism and Diseases (2 works) · Bone mineral (2 works) · China (2 works) · Osteoporosis (2 works) · Alternative medicine (1 work) · Bioinformatics (1 work) · Bone health and treatments (1 work)